Why is Mukka Proteins falling/rising?

As of 24-Sep, Mukka Proteins Ltd is currently priced at 27.20, reflecting a decline of 0.32, or 1.16%. The stock has underperformed its sector today by 0.27%, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has decreased by 2.16%, while it has shown a slight increase of 0.59% over the past month. However, the year-to-date performance is concerning, with a significant drop of 33.74%. The company's financial health is also troubling, as it has reported negative results for the last six consecutive quarters, with net sales falling by 32.1% compared to the previous four-quarter average. Additionally, the company has a high Debt to EBITDA ratio of 4.36 times, indicating a low ability to service its debt, which further contributes to investor concerns.
In the broader market context, Mukka Proteins has underperformed the Sensex, which has increased by 4.58% year-to-date, while Mukka's returns have plummeted by 33.74%. This stark contrast highlights the company's struggles relative to the overall market. Institutional investors have also reduced their stakes in the company by 0.65% over the previous quarter, reflecting a lack of confidence in Mukka's future prospects. The combination of poor management efficiency, low profitability, and declining investor participation suggests that Mukka Proteins is facing significant challenges that are contributing to its falling stock price.